This inventor holds 3 USPTO granted patents and 9 published patent applications and 3 EPO patents. Top assignees: Ac Pharmaceuticals Co., Ltd, Diqi Pharmaceuticals Co., Ltd.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Innovations by Inventor Feng Liu
Introduction
Feng Liu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release drug formulations. With a total of 3 patents, his work focuses on improving the delivery and efficacy of insoluble drugs.
Latest Patents
Feng Liu's latest patents include an "Oral sustained-release composition for insoluble drug" and a "Preparation method of sustained-release microparticles." The oral sustained-release composition is designed for low-dose insoluble drugs and features a unique combination of a sustained-release granule part and a gel skeleton part. This innovative system prolongs the release time of the drug while ensuring a simple preparation process and high efficiency. The second patent, concerning the preparation of sustained-release microparticles, emphasizes maintaining the bioactivity of high-temperature-sensitive drugs. This method allows for a stable drug concentration during release, overcoming limitations of conventional techniques.
Career Highlights
Throughout his career, Feng Liu has worked with reputable companies such as Ac Pharmaceuticals Co., Ltd and Diqi Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Feng Liu has collaborated with notable professionals in his field, including Fuchun Cao and Shuting Lai. These partnerships have likely enhanced his research and development efforts.
Conclusion
Feng Liu's contributions to pharmaceutical innovations, particularly in sustained-release drug formulations, demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of drug delivery systems and their potential to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile